You're tuned in to Tech Beat.
A troubling story out of China is drawing attention tonight — a couple spent more than eight hundred thousand dollars on an experimental gene-editing therapy for their daughter, only to lose her. The death was never made public by the trial organizers, raising serious questions about transparency, oversight, and who bears accountability when cutting-edge medicine goes wrong.
Shifting to the legal arena, Uber is quietly updating its litigation funding terms in ways critics say would make it significantly harder for drivers, riders, and workers to hold the company accountable in court. Legal observers are warning that the fine print here isn't just corporate boilerplate — it's a structural barrier to justice dressed up as policy.
And a story about trust and basic security hygiene — a longtime Namecheap customer discovered the company had handed control of his domain to an unverified third party simply because that person asked. Thirteen years of loyalty, a domain registered in his name, and apparently none of that was enough to trigger a verification call. It's a reminder that identity verification is only as strong as the humans enforcing it.
Keep surfing. Tech Beat out.
